The metabolic consequences of HIV/TB co-infection
Open Access
- 18 August 2023
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-21
Abstract
Background: The synergy between the human immunodeficiency virus (HIV) and Mycobacterium tuberculosis during co-infection of a host is well known. While this synergy is known to be driven by immunological deterioration, the metabolic mechanisms that contribute to the associated disease burden experienced during HIV/tuberculosis (TB) co-infection remain poorly understood. Furthermore, while anti-HIV treatments suppress viral replication, these therapeutics give rise to host metabolic disruption and adaptations beyond that induced by only infection or disease. Methods: In this study, the serum metabolic profiles of healthy controls, untreated HIV-negative TB-positive patients, untreated HIV/TB co-infected patients, and HIV/TB co-infected patients on antiretroviral therapy (ART), were measured using two-dimensional gas chromatography time-of-flight mass spectrometry. Since no global metabolic profile for HIV/TB co-infection and the effect of ART has been published to date, this pilot study aimed to elucidate the general areas of metabolism affected during such conditions. Results: HIV/TB co-infection induced significant changes to the host’s lipid and protein metabolism, with additional microbial product translocation from the gut to the blood. The results suggest that HIV augments TB synergistically, at least in part, contributing to increased inflammation, oxidative stress, ART-induced mitochondrial damage, and its detrimental effects on gut health, which in turn, affects energy availability. ART reverses these trends to some extent in HIV/TB co-infected patients but not to that of healthy controls. Conclusion: This study generated several new hypotheses that could direct future metabolic studies, which could be combined with other research techniques or methodologies to further elucidate the underlying mechanisms of these changes.Keywords
Funding Information
- National Research Foundation, South Africa (122116, 129871)
- North-West University
This publication has 105 references indexed in Scilit:
- Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite ControllersPLOS ONE, 2013
- Nuclear Magnetic Resonance Based Profiling of Biofluids Reveals Metabolic Dysregulation in HIV-Infected Persons and Those on Anti-Retroviral TherapyPLOS ONE, 2013
- Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitorsBMC Infectious Diseases, 2013
- Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophilsJournal of Biomedical Science, 2012
- Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis PatientsPLOS ONE, 2012
- Tuberculosis and HIV Co-InfectionPLOS Pathogens, 2012
- GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA)BMC Bioinformatics, 2011
- HIV and Tuberculosis: a Deadly Human SyndemicClinical Microbiology Reviews, 2011
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- Metagenomic Analysis of the Human Distal Gut MicrobiomeScience, 2006